Jean Liu
Director/Board Member at CONNECT BIOPHARMA HOLDINGS LIMITED
Net worth: - $ as of 2024-03-30
Profile
Jean I.
Liu is currently serving as a Director at Suzhou Connect Biopharma Co. Ltd.
and as an Independent Director at Erasca, Inc. and Connect Biopharma Holdings Ltd.
She is also a Member of The State Bar of California.
Previously, she served as a Director at Cascadian Therapeutics LLC, Secretary, Senior Vice President & General Counsel at DURECT Corp., Secretary & Chief Legal Officer at Seagen Inc., Secretary, Vice President & General Counsel at Halozyme Therapeutics, Inc., and as an Attorney at Pillsbury Madison & Sutro LLP and Venture Law Group.
She holds graduate degrees from The Trustees of Columbia University in The City of New York and Stanford University, and an undergraduate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-02-28 | 0 ( -.--% ) | - $ | 2024-03-30 | |
ERASCA, INC.
-.--% | 2023-12-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
Jean Liu active positions
| Companies | Position | Start |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 2021-08-22 |
| ERASCA, INC. | Director/Board Member | 2022-04-24 |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Director/Board Member | - |
Former positions of Jean Liu
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | General Counsel | 2023-12-13 |
| HALOZYME THERAPEUTICS, INC. | General Counsel | 2014-11-06 |
| DURECT CORPORATION | Consultant / Advisor | - |
Venture Law Group
 Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 1998-09-30 |
| Pillsbury Madison & Sutro LLP | Corporate Officer/Principal | 1997-04-30 |
Training of Jean Liu
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Stanford University | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| DURECT CORPORATION | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private companies | 6 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
| Pillsbury Madison & Sutro LLP | Commercial Services |
Venture Law Group
Venture Law Group Miscellaneous Commercial ServicesCommercial Services Venture Law Group provided law and legal services. The firm specialized in mergers and acquisitions, bankruptcy and restructuring, taxation, labor and employment, intellectual property, technology licensing, corporate partnerships, and executive compensation. The company was founded in 1993 and is headquartered in Menlo Park, CA. | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Commercial Services |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
- Stock Market
- Insiders
- Jean Liu
